LH
Labcorp Holdings Inc.
$259.93
+4.18
(+1.63%)
Mkt Cap
21.31B
Volume
331,650
52W Range
241.81-293.72
Sector
Healthcare
Beta
0.88
EPS (TTM)
11.37
P/E Ratio
22.86
Revenue (TTM)
14.14B
Rev Growth (5Y)
-0.0%
EPS Growth (5Y)
-8.0%
AlphaVal · Fair Value
$239.72
Overvalued · Mild
8.4% above fair value
AlphaQuality · Grade
C
Stable Earnings Power
54.6 / 100 composite
Company Description
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B | 11.55B | 11.33B | 10.44B | 9.64B | 8.68B | 6.01B |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B | 1.56B | 823.80M | 883.70M | 1.27B | 732.10M | 436.90M | 511.20M |
| EPS | 10.54 | 8.89 | 4.80 | 14.04 | 24.58 | 15.99 | 8.41 | 8.71 | 12.39 | 7.14 | 4.42 | 6.03 |
| Free Cash Flow | 1.21B | 1.10B | 874.10M | 1.47B | 2.65B | 1.75B | 1.04B | 925.60M | 1.14B | 897.00M | N/A | N/A |
| FCF / Share | 14.50 | 13.06 | 10.04 | 16.18 | 27.40 | 18.02 | 10.67 | 9.13 | 11.17 | 8.75 | N/A | N/A |
| Operating CF | 1.64B | 1.59B | 1.33B | 1.96B | 3.11B | 2.14B | 1.44B | 1.31B | 1.46B | 1.18B | N/A | N/A |
| Total Assets | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B | 20.07B | 18.02B | 16.19B | 16.57B | 14.25B | N/A | N/A |
| Total Debt | 7.20B | 7.27B | 5.95B | 6.25B | 6.34B | 6.76B | 7.11B | 6.06B | 6.76B | 5.85B | N/A | N/A |
| Cash & Equiv | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B | 1.32B | 337.50M | 426.80M | 316.60M | 433.60M | N/A | N/A |
| Book Value | 8.62B | 8.05B | 7.88B | 10.10B | 10.27B | 9.44B | 7.57B | 6.97B | 6.80B | 5.51B | N/A | N/A |
| Return on Equity | 0.10 | 0.09 | 0.05 | 0.13 | 0.23 | 0.16 | 0.11 | 0.13 | 0.19 | 0.13 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.54B | 3.52B | 3.56B | 3.53B | 3.35B | 3.33B | 3.28B | 3.22B | 3.18B | 3.03B | 3.06B | 3.03B |
| Net Income | 277.80M | 164.70M | 261.10M | 237.90M | 212.80M | 143.40M | 169.30M | 205.30M | 228.00M | (167.10M) | 183.30M | 188.90M |
| EPS | 3.37 | 2.00 | 3.14 | 2.86 | 2.54 | 1.72 | 2.02 | 2.44 | 2.71 | -1.97 | 2.12 | 2.13 |
| Free Cash Flow | 70.50M | 490.30M | 280.50M | 542.70M | (107.50M) | 665.10M | 161.50M | 432.90M | (163.60M) | 412.40M | 170.60M | 237.80M |
| FCF / Share | 0.86 | 5.94 | 3.38 | 6.50 | -1.29 | 7.96 | 1.92 | 5.15 | -1.95 | 4.86 | 1.97 | 2.68 |
| Operating CF | 191.50M | 614.20M | 387.20M | 620.60M | 18.50M | 777.20M | 277.30M | 561.10M | (29.80M) | 579.60M | 275.50M | 341.10M |
| Total Assets | 19.09B | 18.39B | 18.26B | 18.06B | 17.60B | 18.38B | 18.61B | 16.71B | 16.53B | 16.73B | 16.89B | 17.71B |
| Total Debt | 7.24B | 7.21B | 7.22B | 6.55B | 6.52B | 7.27B | 7.72B | 5.98B | 5.97B | 5.95B | 6.33B | 6.21B |
| Cash & Equiv | 981.10M | 532.30M | 598.10M | 647.30M | 369.40M | 1.52B | 1.52B | 265.10M | 99.30M | 536.80M | 727.90M | 1.93B |
| Book Value | 8.73B | 8.62B | 8.70B | 8.47B | 8.31B | 8.05B | 8.17B | 8.01B | 7.96B | 7.88B | 7.87B | 8.79B |
| Return on Equity | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | -0.02 | 0.02 | 0.02 |
LH News
Labcorp (LH) Upgraded to Buy: Here's What You Should Know
Should You Continue to Hold Labcorp Stock in Your Portfolio?
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
LH vs. CRL: Which Stock Is the Better Value Option?
Here's Why Labcorp (LH) Is a Great 'Buy the Bottom' Stock Now
LH Stock Up in Pre-Market on Q1 Earnings & Revenue Beat, 2026 View Up
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
Labcorp Advances As AI Investments, Core Businesses Drive Growth